This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Sep;17(9):1184-6.

doi: 10.1016/S1470-2045(16)30382-5. Epub 2016 Aug 5.

Improvement of outcomes for TP53 carriers

Sharon E Plon¹

Affiliations

PMID: 27501768
DOI: 10.1016/S1470-2045(16)30382-5

Comment

Improvement of outcomes for TP53 carriers

Sharon E Plon. Lancet Oncol. 2016 Sep.

. 2016 Sep;17(9):1184-6.

doi: 10.1016/S1470-2045(16)30382-5. Epub 2016 Aug 5.

Author

Sharon E Plon¹

Affiliation

¹ Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: splon@bcm.edu.

PMID: 27501768
DOI: 10.1016/S1470-2045(16)30382-5

No abstract available

PubMed Disclaimer

Comment on

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.
Villani A, Shore A, Wasserman JD, Stephens D, Kim RH, Druker H, Gallinger B, Naumer A, Kohlmann W, Novokmet A, Tabori U, Tijerin M, Greer ML, Finlay JL, Schiffman JD, Malkin D. Villani A, et al. Lancet Oncol. 2016 Sep;17(9):1295-305. doi: 10.1016/S1470-2045(16)30249-2. Epub 2016 Aug 5. Lancet Oncol. 2016. PMID: 27501770

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal